S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Ligand Pharmaceuticals Incorporated (LGND)
Ligand Pharmaceuticals Incorporated (LGND) Financials

LGND Ligand Pharmaceuticals Incorporated

85.29

0.00 (0.00%)

Pre Market

Last Updated: 03:09:34

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	57.42M	66.09M	27.05M	43.98M	26.37M	34.99M	28.1M	30.98M
Operating Income	-469k	636k	12.18M	14.21M	-1.98M	3.08M	-3.36M	2.99M
Pre Tax Income	-636k	857k	55.93M	55.54M	3.17M	-12.14M	17.1M	113.45M
Net Income	-895k	404k	-17.49M	41.95M	2.29M	-10.27M	18.19M	86.14M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	1.41M	1.52M	10.9M	14.81M	-2.86M	-1.22M	1.38M	600k
EBITDA	12.99M	13.92M	9.81M	23.7M	24.59M	-4.47M	4.63M	11.75M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	108.97M	141.1M	251.45M	120.28M	186.42M	314.73M	196.25M	131.31M
Operating Income	40.55M	66.03M	213.91M	-5.72M	8.73M	78.9M	3.04M	9.82M
Pre Tax Income	7.96M	57.23M	173.33M	796.64M	-10.54M	47.3M	36.01M	63.66M
Net Income	-1.64M	12.56M	143.32M	629.3M	-2.99M	57.14M	-33.36M	52.15M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-0.078	0.594	6.902	37.407	-0.186	3.408	-1.968	2.991
EBIT	20.14M	68.63M	207.61M	801.07M	25.74M	70.04M	7.22M	9.99M
EBITDA	51.39M	78.55M	230.61M	38.01M	36.25M	129.96M	41.07M	46.34M

Ligand Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions